Octadecyl DI-tert-butyl-4-hydroxyhydrocinnamate → 2,4-Di-tert-butylphenol

HRID 2403076

Reaction equation

HRID 2403076 reaction equation
C[C:2]1[CH:7]=[C:6]([C:8]([CH3:11])([CH3:10])[CH3:9])[C:5](O)=[C:4]([C:13]([CH3:16])([CH3:15])[CH3:14])[CH:3]=1.CC(C1C=C(C(C2C=[CH:68][C:67]([OH:70])=[C:66](C(C)(C)C)C=2)(C)CC(OCCOC(=O)CC(C2C=CC(O)=C(C(C)(C)C)C=2)(C2C=CC(O)=C(C(C)(C)C)C=2)C)=O)C=CC=1[OH:27])(C)C.CC(C1C(O)=C(C(C)(C)C)C=C(CCC(OCC(COC(CCC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)=O)(COC(CCC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)=O)COC(CCC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)=O)=O)C=1)(C)C.CC1C(CC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)=C(C)C(CC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)=C(C)C=1CC1C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=1.C(C1C=C(CCC([O-])=O)C=C(C(C)(C)C)C=1O)(C)(C)C.CCCCCCCCCCCCCCCCCCOC(CCC1C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=1)=O.C(C1C=C(C=C(C(C)(C)C)C=1O)CN1C(=O)N(CC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)C(=O)N(CC2C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=2)C1=O)(C)(C)C.C([O:350][P:351]1OCC2(COP(OCCCCCCCCCCCCCCCCCC)OC2)C[O:352]1)CCCCCCCCCCCCCCCCC.S(CCC(OCCCCCCCCCCCC)=O)[CH2:382]CC(OCCCCCCCCCCCC)=O.S(CCC([O-])=O)CCC([O-])=O>>[P:351]([O-:352])([O:350][C:13]([CH3:14])([CH3:15])[CH3:16])[O:70][C:67]([CH3:382])([CH3:68])[CH3:66].[CH3:14][C:13]([C:4]1[CH:5]=[C:6]([C:8]([CH3:11])([CH3:10])[CH3:9])[CH:7]=[CH:2][C:3]=1[OH:27])([CH3:16])[CH3:15]

Participants

12

Reactant 10

HCID 16386Octadecyl DI-tert-butyl-4-hydroxyhydrocinnamateHCID 19645Distearyl pentaerythritol diphosphiteHCID 31250Propanoic acid, 3,3'-thiobis-, didodecyl esterHCID 314042,6-Di-tert-butyl-4-methylphenolHCID 64819Antioxidant 1010HCID 743701,3,5-Trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene2×HCID 93115Tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate2×HCID 122891Butyric acid, 3,3-bis(3-tert-butyl-4-hydroxyphenyl)ethylene esterHCID 1549624HCID 1549624, compoundHCID 38106683-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionate

Product 2

HCID 73112,4-Di-tert-butylphenolHCID 21959072Di-tert-butyl phosphite

Procedure

Preferably, the outer and inner layers comprise antioxidants as authorized by the European Pharmacopeia, such as butylhydroxytoluene; ethylene bis(3,3-bis(3(1,1-dimethylethyl)-4-hydroxy-phenyl) butanoate); pentaerythrityl tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate) or IRGANOX 1010®, 4,4′,4″-(2,4,6 trimethylbenzene-1,3,5-tri-yltrismethylene)-tris(2,6-bis(1,1-dimethyl-ethyl)phenol) also designated IRGANOX 1330®; octadecyle 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate or IRGANOX 1076®; phosphite tris(2,4-bis(1,1-dim ethylethyl)-phenyl) or IRGAPHOS 168®; 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1H,3H,5H)-trione or IRGANOX 3114®; 2,2′-bis(octadecyloxy)-5,5′-spirobi(1,3,2-dioxaphosphinane); dioctadecyle disulfide, didodecyl 3,3′-thiodipropanoate; dioctadecyle 3,3′-thiodipropanoate; or a mixture of seven components that are obtained from the reaction of di-tert-butyl phosphite with trichloride biphosphorus, with biphenyle and 2,4-bis(1,1-dimethylethyl)phenol; copolymer of dimethyl succinate and of (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol, or a mixture of at least two of these additives.

Workup

  1. additionor a mixture of seven components that

Sources & evidence

ORD record
ord-6e85e4e2ef0344a5961f59b04b2ada5e
Source dataset
uspto-grants-2014_08
Patent number
US08802209B2

Linked notes

Loading…